Commentary |

Bidi Cigarettes: An Emerging Threat to Adolescent Health

Karl L. Yen, MD; Elizabeth Hechavarria, BA; Susan B. Bostwick, MD
Arch Pediatr Adolesc Med. 2000;154(12):1187-1189. doi:10.1001/archpedi.154.12.1187.
Text Size: A A A
Published online


The bidi cigarette, or bidi, is a dangerous tobacco product that has rapidly been gaining popularity in the United States during the past few years, particularly with adolescents. Bidis, which are imported from India and sold in convenience stores and gas stations, are being marketed as a new, safe, and natural alternative to regular cigarettes. The cured flakes and dust of dark tobacco leaves are hand-rolled in dried tendu leaves (a broad-leafed plant native to India) and tied at both ends with colorful thread. The unfiltered final product is a small, slim cigarette whose appearance resembles that of a marijuana cigarette. Various flavorings, including vanilla, chocolate, strawberry, and root beer, are added to mask the poor quality of the tobacco. Bidis are sold for around $2 for a pack of 20, which is approximately half the price of regular cigarettes. Walk into a convenience store in a major American city such as New York, and one will likely find bidis displayed behind the counter, beside a cache of Beanie Babies. However, unlike their furry shelf companions of equally innocuous-sounding name, bidis are anything but harmless and are unlikely to disappear any time soon.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles